David White is an international business developer and entrepreneur. He is owner and/or director of a number of companies that deal with highly technical products, including electronics, mechanical engineering, motion control systems, software development, machine tool and robotics research and development, among others. David is personally responsible for the development of a wide range of advanced engineering and manufacturing products which his companies produce in Australia and export to manufacturers around the world.
In 2015, David became grandfather to Scarlett Rose who was diagnosed with Cystic Fibrosis at the age of one month. She was a beautiful, yet sickly baby who failed to thrive and contracted bacterial lung infections early on. Scarlett was unresponsive to a lengthy program of antibiotics that lasted for over 6 months.
Unsatisfied with the current status of cystic fibrosis therapies, David was quick to apply his research and development skills to finding answers to this terrible genetic disease. He left no stone unturned in his search for novel treatments that had a solid scientific basis and proven effective.
David was elated to find early success with new therapies that were able to completely cure Scarlett’s lung infection. Although Scarlett was now healthy and infection free, David knew it would only be a matter of time before she became affected by the long term degradation that is common amongst cf patients. He continued to disseminate his findings to any that would listen, all the while continuing his search for new and effective treatments.
David founded SRT Biotech, a small medical company that is dedicated to the translation of clinical and neutraceutical drugs and therapies that can improve the quality and length of life for those with cystic fibrosis. SRT Biotech ultimately became the Australian licensee of breakthrough cf therapies that were being created by Planetary Biosciences based in North Carolina, USA.
Eventually David was also invited to directly sit on the board of Planetary Biosciences, and was subsequently appointed as Chief Business Development Officer.
David continues to devote all of his many resources to bringing practical and affordable solutions to the cystic fibrosis community. Scarlett continues to thrive with no further complications from cystic fibrosis. She continues to be the motivation behind his efforts to cure cf.